These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23396439)

  • 21. Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome.
    Komurian-Pradel F; Perret M; Deiman B; Sodoyer M; Lotteau V; Paranhos-Baccalà G; André P
    J Virol Methods; 2004 Mar; 116(1):103-6. PubMed ID: 14715313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters.
    Korf M; Meyer A; Jarczak D; Beger C; Manns MP; Krüger M
    J Viral Hepat; 2007 Feb; 14(2):122-32. PubMed ID: 17244252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.
    Ali Ashfaq U; Ansar M; Sarwar MT; Javed T; Rehman S; Riazuddin S
    Virol J; 2011 Mar; 8():112. PubMed ID: 21388559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites.
    Sun D; Rösler C; Kidd-Ljunggren K; Nassal M
    J Hepatol; 2010 Jun; 52(6):817-26. PubMed ID: 20400195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs.
    Yokota T; Sakamoto N; Enomoto N; Tanabe Y; Miyagishi M; Maekawa S; Yi L; Kurosaki M; Taira K; Watanabe M; Mizusawa H
    EMBO Rep; 2003 Jun; 4(6):602-8. PubMed ID: 12740604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
    Suhy DA; Kao SC; Mao T; Whiteley L; Denise H; Souberbielle B; Burdick AD; Hayes K; Wright JF; Lavender H; Roelvink P; Kolykhalov A; Brady K; Moschos SA; Hauck B; Zelenaia O; Zhou S; Scribner C; High KA; Renison SH; Corbau R
    Mol Ther; 2012 Sep; 20(9):1737-49. PubMed ID: 22735378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication.
    Pei Z; Shi G; Kondo S; Ito M; Maekawa A; Suzuki M; Saito I; Suzuki T; Kanegae Y
    Sci Rep; 2013 Dec; 3():3575. PubMed ID: 24356586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.
    Watanabe T; Hatakeyama H; Matsuda-Yasui C; Sato Y; Sudoh M; Takagi A; Hirata Y; Ohtsuki T; Arai M; Inoue K; Harashima H; Kohara M
    Sci Rep; 2014 Apr; 4():4750. PubMed ID: 24756133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
    Sakamoto N; Tanabe Y; Yokota T; Satoh K; Sekine-Osajima Y; Nakagawa M; Itsui Y; Tasaka M; Sakurai Y; Cheng-Hsin C; Yano M; Ohkoshi S; Aoyagi Y; Maekawa S; Enomoto N; Kohara M; Watanabe M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1437-47. PubMed ID: 17683479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome.
    Wang L; Jeng KS; Lai MM
    J Virol; 2011 Aug; 85(16):7954-64. PubMed ID: 21632751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of HCV RNA replication by baculovirus-mediated shRNA expression.
    Suzuki H; Kaneko H; Tamai N; Miyano-Kurosaki N; Hashimoto K; Shimotohno K; Takaku H
    Nucleic Acids Symp Ser (Oxf); 2005; (49):339-40. PubMed ID: 17150772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization.
    Nouri Aria KT; Sallie R; Sangar D; Alexander GJ; Smith H; Byrne J; Portmann B; Eddleston AL; Williams R
    J Clin Invest; 1993 May; 91(5):2226-34. PubMed ID: 8387544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.
    Pan Q; de Ruiter PE; von Eije KJ; Smits R; Kwekkeboom J; Tilanus HW; Berkhout B; Janssen HL; van der Laan LJ
    FEBS Lett; 2011 Apr; 585(7):1025-30. PubMed ID: 21376045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility.
    Sagan SM; Nasheri N; Luebbert C; Pezacki JP
    Chem Biol; 2010 May; 17(5):515-27. PubMed ID: 20534349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA interference-mediated inhibition of Semliki Forest virus replication in mammalian cells.
    Seyhan AA; Alizadeh BN; Lundstrom K; Johnston BH
    Oligonucleotides; 2007; 17(4):473-84. PubMed ID: 18095875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interference of hepatitis C virus RNA replication by short interfering RNAs.
    Kapadia SB; Brideau-Andersen A; Chisari FV
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2014-8. PubMed ID: 12566571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.
    Kanda T; Steele R; Ray R; Ray RB
    J Virol; 2007 Jan; 81(2):669-76. PubMed ID: 17079316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic and antigenomic chains of hepatitis C virus and hepatitis G virus in serum, liver and peripheral blood mononuclear cells.
    Torres C; Muñoz de Rueda P; Ruiz-Extremera A; Quintero D; Palacios A; Salmerón J
    Rev Esp Enferm Dig; 2002 Nov; 94(11):659-68. PubMed ID: 12690989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line.
    Elbadawy HM; Mohammed Abdul MI; Aljuhani N; Vitiello A; Ciccarese F; Shaker MA; Eltahir HM; Palù G; Di Antonio V; Ghassabian H; Del Vecchio C; Salata C; Franchin E; Ponterio E; Bahashwan S; Thabet K; Abouzied MM; Shehata AM; Parolin C; Calistri A; Alvisi G
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus RNA codes for proteins and replicates: does it also trigger the interferon response?
    Branch AD
    Semin Liver Dis; 2000; 20(1):57-68. PubMed ID: 10895432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.